Based on the aggregated intelligence of 170,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, generic-drug maker Hi-Tech Pharmacal (Nasdaq: HITK) has earned a coveted five-star ranking.

With that in mind, let's take a closer look at Hi-Tech's business and see what CAPS investors are saying about the stock right now.

Hi-Tech facts

Headquarters (Founded) Amityville, N.Y. (1982)
Market Cap $291.45 million
Industry Pharmaceuticals
Trailing-12-Month Revenue $164.63 million
Management Chairman/CEO David Seltzer (since 1998)
CFO William Peters (since 2004)
Return on Equity (Average, Past 3 Years) 17%
Cash/Debt $45.2 million / $756,000
Competitors Mylan (Nasdaq: MYL)
Watson Pharmaceuticals (NYSE: WPI)

Sources: Capital IQ (a division of Standard & Poor's) and Motley Fool CAPS.

On CAPS, 92% of the 186 members who have rated Hi-Tech believe the stock will outperform the S&P 500 going forward. These bulls include toshimelonhead and Usnzth.

Just two weeks ago, toshimelonhead compared Hi-Tech to another potent generic play: "Hi-Tech sells generic prescription drugs, which is how people are saving money on healthcare costs. [Little debt] with much better fundamentals and more room to grow than [Perrigo (Nasdaq: PRGO)], and Perrigo is a solid company in itself."

Over the past five years, in fact, Hi-Tech has grown its bottom line at an annual pace of 47.9% annually. That's faster than generic-drug stocks Mylan (3.5%), Watson (28.4%), and Teva Pharmaceutical (Nasdaq: TEVA) (20.3%), and a whole lot faster than big pharma plays Pfizer (NYSE: PFE) (1.5%) and Johnson & Johnson (NYSE: JNJ) (7.5%).

Last month, CAPS member Usnzth added some color to those growth numbers:

It appears that management has now figured out a working business model and their earnings for the past two years look pretty. They are in the middle of a high demand industry at a time when the population wave need more prescriptions and health care is a huge issue. They have a three prong attack on the market selling prescription drugs, generic drugs, and nutritional products.

Today, [Hi-Tech] has a P/E under 10
Minus the cash, the forward P/E is only 10
30% of shares held by insiders

What do you think about Hi-Tech, or any other stock for that matter? If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future, and on Motley Fool CAPS, thousands of investors are working every day to find them. CAPS is 100% free, so get started!